Paper41283237
PD-1 Expression Promotes Immune Evasion in B-ALL.
Casado-García A and 25 others. Hematol Rep, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. PD-1 Expression Promotes Immune Evasion in B-ALL. Papers, record 41283237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41283237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39642167 | Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell Leukemia. | Cancer Immunol Res | 2025 | https://conductscience.org/library/papers/39642167 | PubMed |
| 2 | 30842609 | PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia. | Leukemia | 2019 | https://conductscience.org/library/papers/30842609 | PubMed |
| 3 | 26408659 | Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility. | Cancer Discov | 2015 | https://conductscience.org/library/papers/26408659 | PubMed |
| 4 | 17344859 | Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. | Nature | 2007 | https://conductscience.org/library/papers/17344859 | PubMed |
| 5 | 35879429 | Natural killer cells in antitumour adoptive cell immunotherapy. | Nat Rev Cancer | 2022 | https://conductscience.org/library/papers/35879429 | PubMed |
| 6 | 33178621 | Pediatric Acute Lymphoblastic Leukemia Patients Exhibit Distinctive Alterations in the Gut Microbiota. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33178621 | PubMed |
| 7 | 25737157 | Generation of human acute lymphoblastic leukemia xenografts for use in oncology drug discovery. | Curr Protoc Pharmacol | 2015 | https://conductscience.org/library/papers/25737157 | PubMed |
| 8 | 25943178 | A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia. | Leukemia | 2015 | https://conductscience.org/library/papers/25943178 | PubMed |
| 9 | 26373277 | FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis. | Cancer Cell | 2015 | https://conductscience.org/library/papers/26373277 | PubMed |
| 10 | 37620322 | Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice. | Nat Commun | 2023 | https://conductscience.org/library/papers/37620322 | PubMed |
| 11 | 37930337 | Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL. | J Exp Med | 2024 | https://conductscience.org/library/papers/37930337 | PubMed |
| 12 | 24013638 | A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. | Nat Genet | 2013 | https://conductscience.org/library/papers/24013638 | PubMed |
| 13 | 36624186 | PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/36624186 | PubMed |
| 14 | 27776115 | Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. | Nat Genet | 2016 | https://conductscience.org/library/papers/27776115 | PubMed |
| 15 | 35732829 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732829 | PubMed |
| 16 | 34616407 | Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation. | Front Immunol | 2021 | https://conductscience.org/library/papers/34616407 | PubMed |
| 17 | 32911536 | An intact gut microbiome protects genetically predisposed mice against leukemia. | Blood | 2020 | https://conductscience.org/library/papers/32911536 | PubMed |
| 18 | 33773925 | An immune window of opportunity to prevent childhood B cell leukemia. | Trends Immunol | 2021 | https://conductscience.org/library/papers/33773925 | PubMed |
| 19 | 30198904 | Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. | J Clin Invest | 2018 | https://conductscience.org/library/papers/30198904 | PubMed |
| 20 | 27265895 | Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. | Nat Commun | 2016 | https://conductscience.org/library/papers/27265895 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41283237
GET https://conductscience.org/api/papers/v1/41283237/authors?page=2